Gross Profit On Sales Veränderung Datum
Abbott USD 5.68B 147M 2023-12
ANI Pharmaceuticals USD 78.23M 5.49M 2023-12
Aurora Cannabis CAD 11.94M 34.41M 2023-03
Bristol-Myers Squibb USD 8.77B 294M 2023-12
Cara Therapeutics USD 3.31M 2.21M 2023-09
Corcept Therapeutics USD 121.96M 5.82M 2023-09
Eisai JPY 140.19B 12.82B 2023-09
Eli Lilly USD 7.57B 73.1M 2023-12
Marinus Pharmaceuticals USD 6.88M 1.19M 2023-09
Pacira USD 133.55M 9.38M 2023-12
Perrigo USD 411.2M 16.8M 2023-09
Pfizer USD 7.58B 3.26B 2023-12
Revance Therapeutics USD 37.36M 536K 2023-09
Supernus Pharmaceuticals USD 144.69M 10.41M 2023-12
United Therapeutics USD 543.7M 4.4M 2023-12



Supernus Pharmaceuticals Bruttoergebnis Vom Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.